BRD2 and ovarian carcinoma: In addition, subgroup survival analysis of ovarian cancer patients with various treatment strategies (Table 4) illustrated that overexpression of BRD2 mRNA was significantly correlated with an improved OS for patients treated with Platin-based chemotherapy compared with low expression.